{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:20:34Z","timestamp":1787962834275,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Intravenous (IV) iron sucrose is claimed to have better safety profile and efficacy in treatment of iron deficiency anemia than conventional oral iron supplements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of the study was to compare the efficacy and safety of IV iron therapy with oral iron supplements in iron deficiency anemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An observational study was carried out by allocating 100 patients with baseline hemoglobin between 5 and 10 g\/dL into two groups of oral iron and IV iron group. Hemoglobin and serum ferritin levels were measured at admission, on day 14 and on day 28. Adverse effect profile for each group was tabulated. Mean and standard deviation were calculated for each group and compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 100 patients participated consisting of 37 males and 63 females. Baseline hemoglobin and serum ferritin for both groups were comparable. After initiation of therapy, hemoglobin in oral iron group raised from 6.45 (0.72) to 8.84 (0.47) on day 14 and to 9.69 (0.47) on day 28. Hemoglobin in IV iron group increased from 6.34 (0.86) to 10.52 (0.61) on day 14 and to 11.66 (0.84) on day 28. Serum ferritin in oral iron group increased from 8.3 (1.9) to 33.8 (1.29) on day 14 and to 43.61 (8.8) on day 28. Serum ferritin in IV iron group raised from 8.23 (4.64) to 148.23 (11.86) on day 14 but decreased to 115.76 (15.3) on day 28. The data were statistically significant for IV iron therapy on day 14 and day 28. Of 100 patients, 18 patients (12 in oral and 6 in IV iron groups) had adverse effects. Among the oral iron group, metallic taste and constipation were major side effects followed by heart burn and nausea. In the IV iron group, arthralgia (4 patients of 6) was the major side effect observed. One patient (of 6) in IV group had hypotension. Anaphylaxis was not observed in any patient in either group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>IV iron therapy is effective and safe for management of iron deficiency anemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_559_20","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T10:08:40Z","timestamp":1595758120000},"page":"3619-3622","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":38,"title":["Oral versus intravenous iron therapy in iron deficiency anemia: An observational study"],"prefix":"10.4103","volume":"9","author":[{"given":"Samarendra N.","family":"Das","sequence":"first","affiliation":[{"name":"Department of Medicine, PRM Medical College, Baripada, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruta","family":"Devi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, SCB Medical College, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhuti B.","family":"Mohanta","sequence":"additional","affiliation":[{"name":"Department of Medicine, IMS and SUM Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Medicine, SCB Medical College, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abinash","family":"Swain","sequence":"additional","affiliation":[{"name":"Department of Medicine, SCB Medical College, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravat K.","family":"Thatoi","sequence":"additional","affiliation":[{"name":"Department of Medicine, SCB Medical College, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7]]},"reference":[{"key":"R2-20260813","article-title":"Worldwide Prevalence of Anaemia 1993-2005","author":"Benoist","journal-title":"WHO Global Database of Anaemia"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(01)05835-4","article-title":"WHO multicentre randomised trial of misoprostol in the management of the third stage of labour","volume":"358","author":"Gulmezoglu","year":"2001","journal-title":"Lancet"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000334877","article-title":"Efficacy and tolerability of accelerated-dose low-molecular-weight iron dextran (cosmofer) in patients with chronic kidney disease","volume":"35","author":"Cooke","year":"2012","journal-title":"Am J Nephrol"},{"key":"R5-20260813","first-page":"173","article-title":"Prevalence of anaemia in pregnant and lactating women in India","volume":"124","author":"Agarwal","year":"2006","journal-title":"Indian J Med Res"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7748\/ns2008.08.22.48.35.c6635","article-title":"Intravenous iron administration in a short-stay hospital setting","volume":"22","author":"Peebles","year":"2008","journal-title":"Nurs Stand"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1080\/00016340802317802","article-title":"A 12-week randomised study comparing intravenous iron sucroseversus oral ferrous sulphate for treatment of postpartum anemia","volume":"87","author":"Westad","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R8-20260813","first-page":"628","article-title":"Iron deficiency and other hypoproliferative anemias.Harrison's principles of internal medicine","author":"Adamson","year":"2008"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1079\/BJN2002577","article-title":"Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex","volume":"88","author":"Parewunsnyk","year":"2002","journal-title":"Br J Nutr"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"01","DOI":"10.9790\/0853-1060103","article-title":"Prevalence of Anaemia among OPD Patients of a Tertiary Care Hospital of Eastern India","volume":"10","author":"Chattopadhyay","year":"2013","journal-title":"IOSR Journal of Dental and Medical Sciences"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2141.1999.01179.x","article-title":"Pharmacokinetics and red cell utilization of iron (III) hydroxide-sucrose complex in anaemic patients: A study using positron emission tomography","volume":"104","author":"Beshara","year":"1999","journal-title":"Br J Haematol"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2006.01062.x","article-title":"Intravenous versus oral iron therapy for postpartum anaemia","volume":"113","author":"Bhandal","year":"2006","journal-title":"BJOG"},{"key":"R14-20260813","first-page":"38","article-title":"Intravenous administration of iron sucrose for treating anaemia in postpartum women","volume":"13","author":"Giannoulis","year":"2009","journal-title":"Hippokratia"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0301-2115(95)02538-3","article-title":"Intravenous iron sucrose complex in the treatment of iron deficiency anaemia during pregnancy","volume":"69","author":"Al-Momen","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S2352-3026(19)30264-9","article-title":"Intravenous iron: A framework for changing the management of iron deficiency","volume":"7","author":"Auerbach","year":"2020","journal-title":"Lancet Haematol"},{"issue":"Suppl 2","key":"R17-20260813","doi-asserted-by":"crossref","first-page":"s15","DOI":"10.1016\/S0301-2115(05)80402-6","article-title":"Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route","volume":"123","author":"Bayoumeu","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"c55","DOI":"10.1159\/000085049","article-title":"Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis","volume":"100","author":"Charytan","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/ijph.IJPH_464_18","article-title":"Intravenous Iron sucrose and change in hemoglobin, ferritin, and oxidative stress markers among moderately anemic pregnant women attending a secondary care level Hospital in Northern India","volume":"64","author":"Jacob","year":"2020","journal-title":"Indian J Public Health"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/ajkd.2001.28587","article-title":"Intravenous iron sucrose: Establishing a safe dose","volume":"38","author":"Chandler","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_559_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:19:33Z","timestamp":1787843973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_559_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_559_20","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"2020-04-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}